The Development Pathway for Biosimilar Biotherapeutics

J Ophthalmic Vis Res. 2020 Aug 6;15(3):273-274. doi: 10.18502/jovr.v15i3.7444. eCollection 2020 Jul-Sep.

Author

Affiliation

¹ Institute of Ophthalmology and Visual Science, New Jersey Medical School, Rutgers University, Newark, USA.

No abstract available

Publication types

Editorial